IGI and AbbVie announce exclusive global licensing agreement for ISB 2001
IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
research
XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer:…
Pfizer and Astellas Pharma has announced positive topline results from the overall survival (OS) analysis from the Phase 3 EMBARK…
New study reveals potential link between delirium and dementia
The study shows that patients who had at least one episode of delirium while in hospital went on to develop dementia at triple the…
Scientists find potential new drug target to prevent Ebola
The finding, published in the journal PLOS Biology, not only deepens our understanding of how the virus works, but also offers a…
Scientists investigate if prostate drug could also treat breast cancer that’s spread to the bone
When breast cancer cells spread to other parts of the body it is called secondary or metastatic breast cancer and although…
High levels of exposure to COVID virus may reduce protection from vaccination, prior infection:…
The study was performed to understand whether the immunity gained after vaccination or a prior infection was less effective or…
When proteins get stuck at solid: Unlocking the secrets to brain diseases
Nanoscale view of proteins opens window to treat neurodegenerative illness
Waters Corporation and Princeton University signs multi-year research collaboration
Initial collaboration will bring together Waters scientists with Princeton faculty and students to advance research in drug…
Third wave of COVID in India likely to peak in early Feb: Study
The researchers at the Indian Institute of Technology Kanpur modelled the daily data of cases from countries such as the US, UK,…
Brexit deal offers UK access to research and innovation program worth €95.5 bn: GlobalData
The UK-EU trade deal will give the UK researchers and businesses access to Horizon Europe funding on equivalent terms as EU…